Neuroscience services and drug development company NeuroDiscovery Ltd has announced that its 100 per cent owned subsidiary, NeuroSolutions Ltd, has struck a $1 million deal with a US pharmaceutical company.
29/02/2008 - 15:38
NeuroSolutions signs $1m deal with US pharmaceutical player
29/02/2008 - 15:38